Compare OSUR & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSUR | RDIB |
|---|---|---|
| Founded | 2000 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.1M | 256.7M |
| IPO Year | 2000 | N/A |
| Metric | OSUR | RDIB |
|---|---|---|
| Price | $2.91 | $10.82 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 484.0K | 6.4K |
| Earning Date | 05-06-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,064,000.00 | N/A |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.76 | $13.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.08 | $6.70 |
| 52 Week High | $4.22 | $17.40 |
| Indicator | OSUR | RDIB |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 41.41 |
| Support Level | $2.69 | $10.47 |
| Resistance Level | $2.99 | $12.46 |
| Average True Range (ATR) | 0.18 | 0.49 |
| MACD | -0.03 | -0.14 |
| Stochastic Oscillator | 19.40 | 21.27 |
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.